Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02038673
Title An Open-label Phase I Study of Oral ASP5878 at Single and Multiple Doses in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site US402 Orange California 92868 United States Details
Site US401 New York New York 10032 United States Details
Site US404 Cleveland Ohio 44106 United States Details
Site US406 Spartanburg South Carolina 29303 United States Details
Site US410 Fairfax Virginia 22031 United States Details
Site US403 Seattle Washington 98109 United States Details
Site JP122 Chiba Japan Details
Site JP108 Fukuoka Japan Details
Site JP115 Fukuoka Japan Details
Site JP120 Fukuoka Japan Details
Site JP116 Hokkaido Japan Details
Site JP113 Hyogo Japan Details
Site JP103 Ibaraki Japan Details
Site JP111 Ishikawa Japan Details
Site JP119 Kanagawa Japan Details
Site JP101 Kyoto Japan Details
Site JP109 Miyagi Japan Details
Site JP110 Miyagi Japan Details
Site JP112 Nagoya Japan Details
Site JP117 Niigata Japan Details
Site JP121 Okayama Japan Details
Site JP104 Osaka Japan Details
Site JP106 Osaka Japan Details
Site JP118 Osaka Japan Details
Site JP124 Shizuoka Japan Details
Site JP102 Tokyo Japan Details
Site JP107 Tokyo Japan Details
Site JP123 Tokyo Japan Details
Site KR202 Gyeonggi-do Korea, Republic of Details
Site KR201 Seoul Korea, Republic of Details
Site KR203 Seoul Korea, Republic of Details
Site KR204 Seoul Korea, Republic of Details
Site TW302 Tainan Taiwan Details
Site TW301 Taipei Taiwan Details
Site TW303 Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field